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A B S T R A C T
Aim: Here we aimed at investigating the relation between left ventricular (LV) contractility and myofilament
function during the development and progression of pressure overload (PO)-induced LV myocardial hypertrophy
(LVH).
Methods: Abdominal aortic banding (AB) was performed to induce PO in rats for 6, 12 and 18weeks. Sham
operated animals served as controls. Structural and molecular alterations were investigated by serial echo-
cardiography, histology, quantitative real-time PCR and western blot. LV function was assessed by pressure-
volume analysis. Force measurement was carried out in permeabilized cardiomyocytes.
Results: AB resulted in the development of pathological LVH as indicated by increased heart weight-to-tibial
length ratio, LV mass index, cardiomyocyte diameter and fetal gene expression. These alterations were already
present at early stage of LVH (AB-week6). Furthermore, at more advanced stages (AB-week12, AB-week18),
myocardial fibrosis and chamber dilatation were also observed. From a hemodynamic point of view, the AB-wk6
group was associated with increased LV contractility, maintained ventriculo-arterial coupling (VAC) and pre-
served systolic function. In the same experimental group, increased myofilament Ca2+ sensitivity (pCa50) and
hyperphosphorylation of cardiac troponin-I (cTnI) at Threonine-144 was detected. In contrast, in the AB-wk12
and AB-wk18 groups, the initial augmentation of LV contractility, as well as the increased myofilament Ca2+
sensitivity and cTnI (Threonine-144) hyperphosphorylation diminished, leading to impaired VAC and reduced
systolic performance. Strong correlation was found between LV contractility parameters and myofilament Ca2+-
sensitivity among the study groups.
Conclusion: Changes in myofilament Ca2+ sensitivity might underlie the alterations in LV contractility during
the development and progression of PO-induced LVH.
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1. Introduction
During the development of pressure overload (PO)-induced patho-
logical left ventricular (LV) myocardial hypertrophy (LVH) and its
progression to heart failure (HF) distinct alterations could be observed
in LV contractility. Per definition, the term of contractility defines the
intrinsic ability of the myocardium to contract independently of preload
and afterload [1]. To date, pressure-volume (PeV) analysis represents
the gold standard method to assess the contractile state of the LV in vivo
[2]. Therefore, our knowledge regarding the alterations of LV con-
tractility in PO-induced LVH is derived from PeV analysis data. These
invasive hemodynamic measurements revealed, that the early stage of
LVH is characterized by enhanced LV contractility [3–5]. This con-
tractility augmentation ensures the heart to compensate for the in-
creased PO, thereby maintaining an optimal matching between the
contractile state of the LV and the afterload of the connecting arterial
system (intact ventriculo-arterial coupling; VAC) [6]. Hence, the early
stage of LVH (also referred to as a compensatory stage) is characterized
by preserved systolic function. However, in case of PO-induced patho-
logical LVH, the contractility augmentation provides only a temporary
adaptation. Consequently, at more advanced stages of LVH the initially
enhanced LV contractility declines [5,7]. This leads to an ineffective
contra-regulation of the increased arterial afterload (contractility-
afterload mismatch) that ultimately manifests in reduced systolic per-
formance.
Recently, it has been suggested that chronic PO induces not only
alterations in the contractile state of the LV as an intact organ, but also
certain functional changes at the level of the sarcomere. For instance, in
animal models with LVH and preserved systolic function, increased
myofilament Ca2+ sensitivity (pCa50) was observed [8]. In contrast, in
rodent models of transverse aortic constriction (TAC)-induced LVH with
severely impaired systolic function, reduction in myofilament Ca2+
sensitivity and decreased Ca2+-saturated maximal force (Fmax) was
reported [9,10].
Previous results in permeabilized cardiomyocytes along with data of
PeV analysis indicate that dynamic alterations might occur in sarco-
mere function as well (pCa50 and/or Fmax) during the progression of
LVH. However, to the best of our knowledge none of the previous
studies aimed at investigating isolated, permeabilized cardiomyocyte
function in a longitudinal fashion (repetitive measurements in the same
experimental model to explore timeline alterations) in case of PO-in-
duced LVH. Furthermore, measurement of LV contractility and myofi-
lament function within one, single experiment has neither been as-
sessed.
Therefore, in the present study we aimed to characterize the al-
terations in LV contractility as well as sarcomere function at different
stages of PO-induced LVH in a relevant rat model.
2. Methods
2.1. Animals
The investigation conformed to the EU Directive 2010/63/EU and
the Guide for the Care and Use of Laboratory Animals used by the US
National Institutes of Health (NIH Publication No.85–23, revised 1996).
The experiments were approved by the ethics committee of the Land
Baden-Württemberg for Animal Experimentation (G-94/15). Sprague-
Dawley rats (n=67; 5–6weeks-old; 160-180 g; Janvier, France) were
kept under standard conditions (22 ± 2 °C with 12 h light/dark cycles)
and were allowed access to laboratory rat diet and water ad libitum.
Furthermore, to eliminate any sex-related differences on the develop-
ment of PO-induced LVH, only male rats were used in this study.
2.2. Abdominal aortic banding
After a one-week-long acclimatization period, abdominal aortic
banding (AB) or sham operation was performed, as also described
elsewhere [6]. In brief, under isoflurane anesthesia a midline lapar-
otomy was carried out. Then, the intestinal tract was gently placed
aside and the peritoneal layer was dissected in order to gain access to
the retroperitoneal space. The abdominal aorta between the right renal
artery and the superior mesenteric artery was carefully cleaned from
the surrounding connective tissue. A blunted 22-gauge needle was
utilized to constrict the aorta above the right renal artery. After AB was
completed, the intestines were placed back to the abdominal cavity and
the abdominal muscle layer was sutured in single interrupted fashion.
Finally, the skin wound was closed by applying surgical clips. Following
surgery, analgesia was provided by subcutaneously administered bu-
prenorphine in the dose of 0.05mg/kg. Sham-operated animals were
subjected to the same surgical procedure, except the aortic constriction.
2.3. Experimental groups
Following surgeries, the rats were divided into 6 experimental
groups:
Sham-wk6 group (n=9): after sham operation the rats were fol-
lowed-up for 6 weeks;
AB-wk6 group (n=13): after AB the rats were followed-up for
6 weeks;
Sham-wk12 group (n= 9): after sham operation the rats were fol-
lowed-up for 12 weeks;
AB-wk12 group (n=13): after AB the rats were followed-up for
12 weeks;
Sham-wk18 group (n=10): after sham operation the rats were
followed-up for 18 weeks;
AB-wk18 group (n= 13): after AB the rats were followed-up for
18 weeks, respectively.
2.4. Echocardiography
Echocardiography was carried out using the Vevo® 2100 imaging
system (FujiFilm VisualSonics Inc., Toronto, Ontario, Canada) equipped
with a 21-MHz linear probe according to the previously described
protocol [6]. Repetitive measurements were performed in the AB-wk18
and Sham-wk18 groups at baseline and 3, 6, 9, 12, 15 and 18weeks
after AB/Sham operation. On M-mode recording images, LV internal
diameters (LV end-diastolic diameter [LVEDD] and LV end-systolic
diameter [LVESD]) and anterior (AWT) and posterior wall thicknesses
(PWT) in diastole (d) and systole (s) were measured and LV mass index
(LV mass/body weight) were calculated.
2.5. Pressure–volume analysis
LV PeV analysis was performed according to a previously described
protocol with minor modifications [6]. At the end of the experimental
period (at week 6, 12 or 18 respectively), rats were anaesthetized by
inhalation of 5% isoflurane gas in a chamber. After anesthesia was in-
duced, rats were placed in a supine position on an automatic heating
pad to keep the core temperature at 37 °C. To maintain anesthesia
during the whole hemodynamic measurement, rats were tracheoto-
mized, intubated, and artificially ventilated with 1–1.5% isoflurane gas
in 100% O2. Pancuronium was administered intraperitoneally (in the
dose of 2mg/kg) to induce muscle relaxation. A polyethylene catheter
was inserted into the left external jugular vein for fluid administration.
A 2-Fr microtip pressure-conductance catheter (SPR-838, Millar In-
struments, Houston, TX) was inserted into the right carotid artery and
subsequently advanced into the ascending aorta. After stabilization,
arterial blood pressure was recorded. Then the catheter was guided to
the LV under pressure control. With the use of a special PeV analysis
program (PVAN, Millar Instruments), systolic arterial blood pressure
(SBP), diastolic arterial blood pressure (DBP), mean arterial pressure
(MAP), maximal slope of systolic pressure increment (dP/dtmax) and
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diastolic pressure decrement (dP/dtmin), LV end-systolic volume
(LVESV), LV end-diastolic volume (LVEDV), stroke volume (SV), ejec-
tion fraction (EF), heart rate (HR), cardiac output (CO), stroke work
(SW) were computed and calculated. Furthermore, the integrative
index of arterial afterload, arterial elastance [Ea; calculated by the
following equation: Ea= LVESP/SV [11]], and the time constant of LV
pressure decay [Tau; according to the Glanz method [12]] were also
assessed.
To detect load-independent contractility parameters, PeV loops
were also registered at transiently decreasing preload, which was
achieved by transient occlusion of the inferior caval vein. By this
maneuver, the following load-independent contractility indexes were
calculated: the slope of the end-systolic PeV relationship (ESPVR, ac-
cording to the parabolic curvilinear model [13]), preload recruitable
stroke work (PRSW) and the slope of the dP/dtmax-end-diastolic volume
relationship (dP/dtmax-EDV).
To characterize myocardial stiffness, the slope of the end-diastolic
PeV relationship (EDPVR) was derived.
To assess LV net performance, ventriculo-arterial coupling (VAC)
was determined as the ratio of Ea and ESPVR (VAC=Ea/ESPVR) [14].
Parallel conductance was calculated, and volume calibration of the
conductance system was performed as previously described [2]. After
completion of the hemodynamic measurements, animals were eu-
thanized by exsanguination. After exsanguination, the organs were
perfused in situ with cold (4 °C), oxygenated Ringer solution to elim-
inate erythrocytes from myocardial tissue. Then, heart weights and ti-
bial lengths were quickly measured. The ratio of heart weight-to-tibial
length was calculated to assess the extent of LVH.
2.6. Measurement of permeabilized cardiomyocyte mechanical parameters
In each experimental groups, deep-frozen heart tissue samples from
6 animals were used for cardiomyocyte measurements (N=6). In each
groups, a total of 10–12 cardiomyocytes were measured (n=10–12).
Samples were mechanically isolated in isolating solution [(Iso con-
tained: KCl (100mM), EGTA (2mM), MgCl2 (1mM), Na2ATP (4mM),
imidazole (10mM), pH=7.0) containing phenylmethylsulfonyl
fluoride (PMSF, 0.5mM, Sigma–Aldrich, St. Louis, MO, USA), leupeptin
(40 μM, Sigma–Aldrich), and E-64 (10 μM, Sigma–Aldrich) protease
inhibitors at 4 °C. Cardiomyocytes were permeabilized with 0.5% Triton
X-100 detergent for 4min to remove all membranous structures. Single
isolated and permeabilized cardiomyocytes were mounted between two
thin stainless insect needles by means of silicone adhesive (DAP 100%
all-purpose silicone sealant; Baltimore, MD, USA) at 15 °C. The needles
were connected to a highly sensitive force transducer (SensoNor,
Horten, Norway) and an electromagnetic length controller (Aurora
Scientific Inc., Aurora, Canada). Activating and relaxing solutions were
mainly used during the force measurement procedure. The activating
solution contained: CaEGTA (7mM), KCl (37.34 mM), N,N-bis (2-hy-
droxyethyl)-2-aminoethanesulfonic acid (BES, 10mM), MgCl2
(6.24 mM), Na2ATP (6.99 mM), Na2CrP (15mM), pH=7.2 resulting in
a [Ca2+] of pCa= 4.75 (pCa: -lg[Ca2+]). The relaxing solution con-
tained the same components apart from containing EGTA instead of
CaEGTA, pH=7.2 resulting in a [Ca2+] of pCa= 9. Both solutions
were supplemented with protease inhibitors. Solutions with inter-
mediate calcium concentrations were prepared by mixing relaxing and
activating solutions (pCa 5.4–7.0). The sarcomere length (SL) was ad-
justed to 2.3 μm. The active force (Factive) and Ca2+-sensitivity of force
production were determined in activating solutions with different Ca2+
concentrations. When the maximal active force (Fmax) had been
reached, a quick release-restretch maneuver (30ms) was applied in the
activating solution. The length of the myocyte was reduced by 20%
followed by quick re-stretching the cell back to its initial length (re-
lease–restretch maneuver).
The Ca2+-independent passive tension (Fpassive) was approximated
by shortening of the preparations to 80% of the original lengths in
relaxing solution for 8 s. The cell was then exposed to a series of solu-
tions containing intermediate pCa to construct the pCa-force relation-
ship. Factive at submaximal Ca2+ levels were normalized to the Factive at
maximal Ca2+ level (4.75, Fmax). The relation between the Factive and
pCa was fitted to a modified Hill equation: Ftotal = Fmax[Ca2+]nHill/
(pCa50nHill + [Ca2+]nHill) + Fpassive, where Fmax is the maximal force,
Fpassive is the passive force, Ftotal = Fmax+ Fpassive, [Ca2+] is the cal-
culated Ca2+ concentration, nHill is a constant the slope and the
midpoint of the sigmoidal relationship, respectively. pCa50 illustrated
the Ca2+ concentration at which half of the maximal force was pro-
duced. The values of absolute forces were normalized to myocyte cross
sectional area and expressed in kN/m2.
Ca2+-induced contractures of cardiomyocytes were recorded by a
custom-built LABVIEW Data Acquisition platform and analyzed by
LabVIEW analysing software (Myo; National Instruments, Austin, TX,
USA).
2.7. Western immunoblotting
Cardiomyocytes were isolated and permeabilized from frozen LV
heart tissues, then myocytes were solubilized in sample buffer (con-
taining 8M urea, 2M thiourea, 3% (w/v) sodium dodecyl sulfate (SDS),
75mM DTT, 50mM Tris-HCl, pH 6.8, 10% (v/v) glycerol, 0.5% bro-
mophenol blue, 40 μM leupeptin and 10 μM E-64) for 45min vortexing.
After centrifugation (16,000 g for 5min at 24 °C), protein amount of
supernatant was determined by dot-blot technique using bovine serum
albumin (BSA) standard, and the concentration of samples were set to
2mg/ml. Cardiac troponin-I (cTnI) and myosin binding protein-C
(cMyBP-C) were carried out with 12% and 4% gradient gels. Western
immunoblotting was applied to assess the site-specific phosphorylation
status of cardiac proteins. After protein blotting, the membranes were
blocked with 2% BSA diluted in PBS containing 0.1% (v/v) Tween 20
(PBST) for 30min, then cTnI phosphorylation-sensitive antibodies were
used to determine the levels of protein kinase A (PKA) and protein ki-
nase C (PKC)-dependent cTnI (Ser-23/24 (1:1000), Ser-43 (1:500) and
Thr-144 (1:500), Abcam, Cambridge, UK) and PKA-dependent cMyBP-C
(Ser-282 (1:500, Enzo Life Sciences, Farmingdale, New York) phos-
phorylation. The signal was detected with a peroxidase-conjugated anti-
rabbit IgG secondary antibody (1:300) (Sigma–Aldrich, St.Louis, MO,
USA) on the membranes. Total amount of cTnI was visualized with
super sensitive membrane staining (UD-GenoMed, Debrecen, Hungary).
Chemiluminescence (ECL) signals were normalized to western blot
stain.
2.8. Histology
The hearts were fixed in buffered paraformaldehyde solution (4%)
and embedded in paraffin. Transverse, transmural, 5-μm thick slices of
the ventricles were cut and placed on adhesive slides.
Hematoxylin and eosin staining was performed to define cardio-
myocyte diameter (CD) as a cellular marker of myocardial hypertrophy
[15]. In each sample, 100 longitudinally oriented cardiomyocytes from
the LV were examined, and the diameters at transnuclear position were
measured. The mean value of 100 measurements represented 1 sample.
The extent of myocardial fibrosis was assessed on picrosirius-stained
sections [16]. ImageJ software (NIH, Bethesda, MD) was used to
identify the picrosirius red-positive area. Three transmural images were
randomly taken from the LV wall on each section. After background
subtraction, eye-controlled auto-threshold has been determined to de-
tect positive areas. The collagen area (picrosirius red-positive area – to -
total area ratio) was determined on each image, and the mean value of
three images represents each animal.
2.9. LV mRNA expression analysis
LV mRNA analysis was performed according to the previously
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described protocol [7]. Briefly, LV myocardium was homogenized in a
lysis buffer (RLT buffer; Qiagen, Hilden, Germany). RNA was isolated
using the RNeasy Fibrous Tissue Mini Kit (Qiagen), according to the
manufacturer's instructions. The quality and concentration of the iso-
lated RNA were assessed by the NanoDrop 2000 Spectrophotometer
(Thermo Scientific™, Waltham, MA, USA). Accordingly, optical density
at 230, 260, and 280 nm was measured. The ratios of 230/260 and 230/
280 nm were defined for quality control. Reverse transcription reaction
(1 μg total RNA of each sample) was completed using the QuantiTect
Reverse Transcription Kit (Qiagen). Quantitative real-time PCR was
performed with the StepOnePlus Real-Time PCR System (Applied Bio-
systems, Foster City, CA, USA) in duplicates of each sample in a volume
of 10 μl in each well containing cDNA (1 μl), TaqMan Universal PCR
MasterMix (5 μl), and a TaqMan Gene Expression Assay (0.5 μl) (Ap-
plied Biosystems) for the following genes: atrial natriuretic peptid
(ANP; assay ID: Rn00664637_g1), β-type myosin heavy chain (β-MHC;
assay ID: Rn00568328_m1), α-type myosin heavy chain (α-MHC; assay
ID: Rn00568304_m1). Gene expression data were normalized to gly-
ceraldehyde 3-phosphate dehydrogenase (GAPDH; assay ID:
Rn01775763_g1), and expression levels were calculated using the CT
comparative method (2-ΔCT). All results are expressed as values nor-
malized to a positive calibrator (a pool of cDNA from all samples of the
Sham-wk6 group [2-ΔΔCT]).
2.10. Statistics
All values are expressed as mean ± standard error of the mean. The
distribution of the datasets was tested by D'Agostino-Pearson omnibus
and Shapiro-Wilk normality test.
An unpaired two-sided Student's t-test in case of normal distribution
or Mann-Whitney U test in case of non-normal distribution was used to
compare two independent groups.
Two-way analysis of variance (ANOVA) with the factors “time” and
“aortic banding” were carried out to compare six independent groups.
For values of Ptime, Paortic banding and Pinteraction see Suppl. Table 1. Prior
to two-way ANOVA, those datasets that failed to show normal dis-
tribution were logarithmically transformed. Tukey post hoc test was
utilized to detect intergroup differences.
Repeated-measures one-way ANOVA or Friedman test was per-
formed for comparing data of the echocardiographic measurements at
different time points (week 3, 6, 9, 12, 15 and 18) within a group. To
examine intergroup differences, Holm-Sidak or Dunn post hoc test was
carried out.
According to the distribution of the datasets, Pearson (in case of
normal) or Spearman (in case of not-normal) correlation test was per-
formed to detect correlations between pCa50 and ESPVR, between
pCa50 and PRSW and between pCa50 and dP/dtmax-EDV.
Western immunoblot assays were performed in triplicate. Intensities
of protein bands were quantified by determining the area under the
intensity curves by a Gaussian fit using ImageJ (National Institutes of
Health, Bethesda, MD, USA) and Magic Plot (Saint Petersburg, Russia)
software.
A P value of< 0.05 was used as a criterion for statistical difference.
Furthermore, two additional categories (P < .01 and P < .001) were
introduced to indicate the strength of the observed statistical difference.
2.11. Data availability
The raw data from the current study will be made available by the
corresponding author upon reasonable request.
Table 1
LV and myofilament function in aortic-banded and sham-operated rats at different time points.
Week 6 Week 12 Week 18
Sham (n= 9) AB (n= 13) Sham (n=9) AB (n= 13) Sham (n= 10) AB (n= 13)
SBP, mmHg 148 ± 4 215 ± 4⁎⁎⁎ 138 ± 5 215 ± 5⁎⁎⁎ 150 ± 5 228 ± 4⁎⁎⁎
DBP, mmHg 116 ± 3 150 ± 2⁎⁎⁎ 110 ± 4 154 ± 4⁎⁎⁎ 120 ± 4 170 ± 3⁎⁎⁎###$$
MAP, mmHg 127 ± 4 172 ± 2⁎⁎⁎ 119 ± 4 174 ± 4⁎⁎⁎ 140 ± 4 189 ± 3⁎⁎⁎##$
Ea, mmHg/μl 0.75 ± 0.06 1.20 ± 0.08* 0.68 ± 0.05 1.33 ± 0.10⁎⁎⁎ 0.84 ± 0.05 1.54 ± 0.16⁎⁎⁎
HR, beats/min 355 ± 7 369 ± 9 354 ± 5 366 ± 7 379 ± 7 357 ± 5
dP/dtmax, mmHg/s 8018 ± 314 10,781 ± 283⁎⁎⁎ 8425 ± 365 10,692 ± 374⁎⁎ 9689 ± 322 10,810 ± 518
dP/dtmin, mmHg/s −8587 ± 221 −10,663 ± 343⁎⁎ −9277 ± 344 −9681 ± 249 −10,073 ± 331 −9000 ± 431##
LVEDV, μl 268 ± 16 305 ± 14 286 ± 23 320 ± 20 283 ± 18 327 ± 14
LVESV, μl 175 ± 15 194 ± 12 178 ± 17 231 ± 11 160 ± 11 241 ± 11⁎⁎⁎
SV, μl 188 ± 16 173 ± 10 195 ± 11 163 ± 12 175 ± 10 151 ± 15
CO, ml/min 66.7 ± 6.1 62.9 ± 3.0 69.4 ± 4.5 59.4 ± 4.1 66.3 ± 4.4 53.7 ± 5.4
SW, mmHg*μl 17,314 ± 1300 25,194 ± 1873 18,404 ± 988 22,005 ± 2677 17,674 ± 1296 20,405 ± 1855
EF, % 58 ± 3 51 ± 2 57 ± 2 44 ± 2⁎⁎ 55 ± 2 41 ± 3⁎⁎⁎##
Tau, ms 14.2 ± 0.4 18.4 ± 0.9⁎⁎ 12.8 ± 0.6 19.4 ± 0. 6⁎⁎⁎ 13.0 ± 0.3 21.7 ± 1.2⁎⁎⁎#
EDPVR, mmHg/μl 0.038 ± 0.005 0.038 ± 0.007 0.028 ± 0.004 0.042 ± 0.006 0.014 ± 0.003 0.032 ± 0.004⁎⁎
VAC 0.50 ± 0.08 0.45 ± 0.06 0.54 ± 0.06 0.76 ± 0.08## 0.57 ± 0.10 0.87 ± 0.08###
Fmax, kN/m2 15.3 ± 0.8 13.6 ± 0.7 14.2 ± 0.5 13.1 ± 0.8 13.6 ± 0.8 15.5 ± 1.0
Values are expressed as mean ± standard error of the mean. AB indicates aortic-banding; SBP: systolic arterial blood pressure; DBP: diastolic arterial blood pressure;
MAP: mean arterial pressure; Ea: arterial elastance, HR: heart rate; dP/dtmax: maximal slope of systolic pressure increment; dP/dtmin: maximal slope of diastolic
pressure decrement; LVEDV: LV end-diastolic volume; LVESV: LV end-systolic volume; SV: stroke volume; CO: cardiac output; SW: stroke work; EF: ejection fraction;
Tau: time constant of LV pressure decay according to the Glantz’method; EDPVR: end-diastolic pressure-volume relationship; VAC: ventriculo-arterial coupling; Fmax:
Ca2+-saturated maximal force. *: P < .05 vs. age-matched sham.
⁎⁎ P < .01 vs. age-matched sham.
⁎⁎⁎ P < .001 vs. age-matched sham.
# P < .05 vs. AB-week 6.
## P < .01 vs. AB-week 6.
### P < .001 AB-week 6.
$ P < .05 vs. AB-week 12.
$$ P < .01 vs. AB-week 12.
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3. Results
3.1. Echocardiographic follow-up during the development of PO-induced
LVH
From week 3 until the end of the experimental period, AWTd, PWTd
and LVmassindex were increased in the AB-wk18 group compared to the
sham-wk18 group, indicating the development of LVH (Fig. 1B-D).
Furthermore, at week 12, week 15 and week 18, LVEDD was also in-
creased in the AB-wk18 group compared to the sham-wk18 group,
suggesting chamber dilatation (Fig. 1E).
3.2. Pathological hypertrophy and fibrosis markers in PO-induced LVH
In the AB-wk6, AB-wk12 and AB-wk18 groups, HW/TL and CD were
increased compared to the corresponding sham groups (Fig. 2B–C). The
myocardial mRNA expression levels of β/α-MHC ratio and ANP were
also elevated in the AB groups compared to their corresponding sham
groups, indicating reactivation of the fetal gene program (Fig. 2D–E).
Furthermore, assessment of the myocardial collagen area revealed in-
creased interstitial fibrosis in the AB-wk12 and AB-wk18 groups com-
pared to the sham-wk12 and sham-wk18 groups, respectively (Fig. 2F).
3.3. Myofilament function
pCa50 increased significantly in the AB-wk6 group compared to the
sham-wk6 group, indicating increased myofilament Ca2+ sensitivity
(Fig. 3). This pCa50 value was also significantly higher in the AB-wk6
group than in the AB-wk12 and AB-wk18 groups (Fig. 3). Myofilament
Ca2+ sensitivity in the AB-wk12 and AB-wk18 groups did not differ
from their corresponding sham groups (Fig. 3).
Furthermore, no significant differences could be observed in Fmax
among the experimental groups (Table 1).
3.4. Site-specific phosphorylation of cardiac troponin-I and myosin binding
protein-C
Phosphorylation of cTnI at Ser-22/23 and Ser-43 did not differ
among the study groups (Fig. 4A–B). There was also no difference in the
phosphorylation status of cMyBP-C at Ser-282 (Fig. 4D). In contrast,
phosphorylation of cTnI at the PKC-specific Thr-144 site was sig-
nificantly increased in the AB-wk6 group compared either to the sham-
wk6 group or the AB-wk12 and AB-wk18 groups (Fig. 4C).
3.5. LV function
Hemodynamic results obtained from PeV analysis are summarized
in Figs. 5–7 and Table 1.
3.5.1. Arterial loading
SBP, DBP, MAP and Ea were elevated in the AB groups compared to
the corresponding sham groups, confirming the presence of increased
PO proximal to the aortic constriction (Table 1).
3.5.2. Load-dependent systolic parameters
The AB-wk6 group was associated with preserved systolic perfor-
mance. Accordingly, no difference could be observed in load-dependent
systolic parameters (EF, SV, CO) between the AB and the sham group at
week 6 (Table 1). In contrast, in the AB-wk12 and AB-wk18 groups, EF
decreased significantly, while SV and CO showed a tendency towards
decreased values compared to the corresponding sham groups
(Table 1).
3.5.3. Load-independent contractility parameters
In the AB-wk6 group, ESPVR, PRSW and dP/dtmax-EDV increased
significantly compared to the sham-wk6 group, indicating increased LV
contractility (Figs. 5A–B, 6A–B, 7A–B). This contractility augmentation
diminished in the AB-wk12 and AB-wk18 groups. Accordingly, the
load-independent contractility parameters were not different in the AB-
Fig. 1. Echocardiographic follow-up during the development of pressure overload-induced LVH.
Representative M-mode echocardiographic images at the midpapillary muscle level are shown at week 6, 12 and 18 (A). The temporal development of pressure
overload-induced left ventricular (LV) myocardial hypertrophy in the aortic-banded (AB) group (AB-wk18 group) was associated with increased anterior wall
thickness in diastole (AWTd) (B), increased posterior wall thickness in diastole (PWTd) (C) and increased LV mass index (D) compared to the corresponding sham
group (sham-wk18 group). Furthermore, from week 12 to week 18, increment in LV end-diastolic diameter revealed chamber dilatation in the AB-wk18 group. *:
P < .05 vs. corresponding sham. **: P < .01 vs. corresponding sham. ***: P < .001 vs. corresponding sham. †: P < .05 vs. week 3. ‡: P < .05 vs. week 6. #:
P < .05 vs. week 9.
M. Ruppert, et al. Journal of Molecular and Cellular Cardiology 129 (2019) 208–218
212
Downloaded for Anonymous User (n/a) at HUNGARY - Debrecen University from ClinicalKey.com by Elsevier on March 22, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.
Fig. 2. Pathological hypertrophy markers at different stages of pressure overload-induced LVH.
Representative photomicrographs of hematoxylin and eosin (magnification 200×, scale bar: 40 μm) and picrosirius red staining (magnification 50×, scale bar:
200 μm) are shown demonstrating enlargement of cardiomyocytes and insterstitital collagen accumulation in the aortic-banded (AB) groups (A). The development of
pressure overload-induced left ventricular myocardial hypertrophy (LVH) was confirmed by increased heart weight-to-tibial length ratio (HW/TL) (B) and cardio-
myocyte diameter (CD) (C) in the AB groups at week 6, 12 and 18 compared to the corresponding sham groups. The pathological nature of LVH was reflected by
markers of the fetal gene program (beta-to-alpha myosin heavy chain ratio [β/α-MHC] and atrial natriuretic peptide [ANP]) (D-E). Furthermore, in the AB groups at
week 12 and 18, the extent of collagen area increased significantly compared to the corresponding sham groups. *: P < .05. **: P < .01. ***: P < .001. (For
interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 3. Myofilament Ca2+ sensitivity in pressure overload-induced LVH.
pCa-force relationship of permeabilized cardiomyocytes revealed increased myofilament Ca2+-sensitivity (pCa50) in the aortic-banded (AB) group at week 6 com-
pared to the corresponding sham group and also to the AB groups at week 12 and 18. Experimental values are derived from 6 animals (N=6) and 10–12
cardiomyocytes (n=10–12) per group. ***: P < .001.
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wk12 and AB-wk18 groups compared to sham-wk12 and sham-wk18
groups, but they were significantly decreased compared to the AB-wk6
group (Figs. 5A–B, 6A–B).
3.5.4. Ventriculo-arterial coupling
In the AB-wk6 group, the enhanced LV contractility (increased
ESPVR) counterbalanced the elevated afterload (increased Ea), there-
fore VAC did not differ from the corresponding sham group (Table 1). In
contrast, in the AB-wk12 and AB-wk18 groups, the lack of compensa-
tory LV contractility augmentation (reduced ESPVR values compared to
AB-wk6) along with the elevated afterload (increased Ea) resulted in
contractility-afterload mismatch. Thus, the values of VAC were sig-
nificantly higher in the AB-wk12 and AB-wk18 groups compared to that
of the AB-wk6 group (Table 1).
3.5.5. Diastolic function
Tau increased significantly in the AB-wk6, AB-wk12 and AB-wk18
groups compared to their corresponding sham groups (Table 1). Fur-
thermore, the slope of EDPVR was also elevated in the AB-wk18 group
compared to the sham-wk18 group (Table 1).
3.6. Correlation between myofilament Ca2+ sensitivity and LV contractility
parameters
Strong correlations were detected between the load-independent LV
contractility parameters (ESPVR, PRSW and dP/dtmax-EDV) and myo-
filament Ca2+ sensitivity (pCa50) (Figs. 5–7).
4. Discussion
The present paper is the first that demonstrates a strong correlation
between myofilament Ca2+ sensitivity of permeabilized cardiomyo-
cytes (pCa50) and PeV analysis derived LV contractility parameters
(ESPVR, PRSW, dP/dtmax-EDV) in a rat model of PO-induced LVH. Our
results indicate that changes in myofilament Ca2+ sensitivity might
underlie the alterations in LV contractility during the development and
progression of PO-induced LVH.
4.1. Structural and molecular characterization of AB-induced LVH
In the current study the abdominal AB rat model was used to in-
vestigate PO-induced remodeling of the LV. Consistently with our
previous experiences with this model [4,6,7,16], AB evoked the de-
velopment of marked LVH, as indicated by echocardiographic data
(increased wall thicknesses and LVmassindex) (Fig. 1B–D), post mortem
measurement (increased HW/TL) and histological analysis (increased
CD) (Fig. 2A–C). The pathological nature of LVH was confirmed by the
reactivation of the fetal gene program (enhanced β/α-MHC ratio and
ANP mRNA levels) (Fig. 2D–E) [17]. All of these structural and mole-
cular alterations were already present after 6 weeks of AB. In addition,
Fig. 4. Site-specific phosphorylation of cardiac troponin-I and myosin binding protein-C.
Western blot analysis revealed unaltered phosphorylation of cTnI at Ser-22/23 (4A) and Ser-43 (4B) and cMyBP-C at Ser-282 (4D) among the study groups. In
contrast, phosphorylation of cTnI at Thr-144 increased significantly in the AB-wk6 group compared to the corresponding sham group and also the AB-wk12 and AB-
wk18 groups (4C). **: P < .01. ***: P < .001.
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at later time points (week 12 and week 18) AB was also associated with
chamber dilatation and progressive accumulation of interstitial col-
lagen content (Fig. 1E, Fig. 2F), which is also in good agreement with
prior findings [18].
4.2. Longitudinal assessment of LV function in PO-induced LVH by PeV
analysis
Currently, PeV analysis represents the gold standard method to
reliably measure in vivo LV hemodynamics [2]. Of particular interest,
the assessment of the PeV loops at different preloads enables us to
calculate LV contractility parameters, independently of loading condi-
tions. Therefore, this technique is extremely valuable in pathological
states, where the robust alterations in pre- and/or afterload (e.g. AB-
induced chronic PO) make the conventional load-dependent parameters
inappropriate to characterize LV function. For these reasons, PeV
analysis was utilized in the present investigation as well, to explore
timeline alterations in LV hemodynamics at different stages of PO-in-
duced LVH.
Early stage of PO-induced LVH. The early stage of PO-induced LVH is
typically associated with impaired diastolic function (predominantly
prolonged active relaxation) [19], and preserved systolic performance.
Although, at this stage, the conventional load-dependent systolic in-
dexes show no alteration, assessment of PeV analysis-derived, load-
independent indexes revealed robust augmentation of LV contractility
[4,6,16]. This increment in LV contractility allows the LV to compen-
sate for the increased afterload, thereby maintaining an optimal inter-
action between the LV and the arterial system. Based on our previous
experiences with the abdominal AB model [4,16], week 6 was chosen as
a time point to investigate the early stage of LVH. According to our
expectations, in the AB group at this time point diastolic dysfunction
was already present (indicated by prolonged Tau), but the load-
dependent systolic indexes (e.g. EF) were preserved (Table 1). To
characterize LV contractility independently from extrinsic conditions,
three load-independent, gold standard parameters (ESPVR, PRSW and
dP/dtmax-EDV) were calculated from PeV analysis data [2]. All of these
indexes confirmed augmented LV contractility in the AB group
(Figs. 4B, 5B, 6B). Furthermore, assessment of VAC ratio confirmed an
adequate matching between LV contractility and the afterload of the
connecting arterial system (Table 1). Therefore, from a hemodynamic
point of view, the AB group at week 6 met the criteria of an early stage
of PO-induced LVH.
Advanced stages of PO-induced LVH. In case of PO-induced patholo-
gical LVH, the contractility augmentation provides only temporary
adaptation. Accordingly, after a certain period of time, the initially
increased LV contractility regresses, despite of the persistently elevated
PO [5,6]. In animal models of chronic PO-induced LVH, the time point
when LV systolic dysfunction is expected to develop is dependent on the
species of the experimental animal (mice versus rat), the location of the
banding suture (thorax versus abdomen) and the severity of the applied
constriction (severe versus moderate) [20]. Our experience from pre-
vious consecutive studies with the abdominal AB rat model indicates,
that an early transition from “compensated” LVH to systolic dysfunction
takes place after 12 weeks of chronic PO in male AB rats [6]. Thus, in
the current study, week 12 and week 18 were selected to study ad-
vanced stages of LVH. At these time points, the PeV analysis derived
contractility indexes were substantially reduced compared to that of the
early stage of LVH (AB-wk6 group) (Fig. 4B, 5B, 6B). The decom-
pensation of the hypercontractile state along with increased arterial
loading condition (Ea) resulted in contractility-afterload mismatch
(impaired VAC ratio) (Table 1). Therefore, at these time points the net
systolic performance was decreased, which was reflected by a slight
reduction in load-dependent systolic parameters (e.g. EF) (Table 1).
Furthermore, the AB-wk18 group was also associated with marked
Fig. 5. Correlation between the slope of the end-systolic pressure-volume relationship and myofilament Ca2+ sensitivity during the progression of PO-induced LVH.
Assessment of the slope of the end-systolic pressure-volume relationship (ESPVR) revealed increased left ventricular (LV) contractility in the aortic-banded (AB)
group at week 6 compared to the corresponding sham group and also to the AB groups at week 12 and 18 (A-B). Alterations in ESPVR and pCa50 showed a strong
correlation among all the study groups (C) and also among only the AB groups (D). No correlation could be detected among the Sham groups (E). LVH indicates left
ventricular hypertrophy; PO: pressure overload. **: P < .01. ***: P < .001.
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impairment of both aspects (active relaxation and passive stiffness) of
diastolic function (Table 1).
4.3. Myofilament function in PO-induced LVH and its correlation to global
LV function
The force generation of cardiomyocytes is eventually dependent on
sarcomere function [21]. Therefore, it is reasonable to hypothesize that
certain alteration might occur in myofilament function during the de-
velopment and progression of PO-induced LVH that underlie the ob-
served changes in LV contractility. This is further supported by the fact
that former studies reported increased, unaltered and decreased cardiac
myocyte function at different stages of PO-induced pathological LVH
[8–10,22]. However, these studies share common limitations that
warrants the need for further experimentations. First of all, most of the
previous investigations analyzed myofilament function at only one
specific time point (cross sectional studies). Consequently, we have
limited data regarding the timeline of sarcomere changes in PO-induced
LVH. Furthermore, none of the mentioned investigations assessed LV
contractility in the same experimental model. Hence, our knowledge
how the reported changes of myofilament function appear on global LV
hemodynamics is also limited. Therefore, in the present investigation,
we aimed to detect myofilament function and LV contractility from the
same experimental animals at different stages of PO-induced LVH.
Early stage of PO-induced LVH. As we pointed it out above, the early
stage of PO-induced LVH (AB-wk6 group) was associated with in-
creased contractility (ESPVR, PRSW, dP/dtmax-EDV) on the global LV
level. In the same experimental group, we observed enhanced Ca2+-
sensitivity (pCa50) and unaltered Fmax of permeabilized LV cardio-
myocytes (Fig. 3 and Table 1). Therefore, our results indicate that in-
creased myofilament Ca2+-sensitivity held responsibility for the con-
tractility augmentation on the cellular level during the early-phase of
PO-induced LVH. Although, this kind of relation between myofilament
Ca2+-sensitivity and LV contractility in pathological LVH has not been
postulated yet, numerous groups have reported increased sarcomere
Ca2+-sensitivity in pathological LVH with preserved systolic function
[8,23]. Furthermore, to define the underlying molecular mechanism for
the increased myofilament Ca2+-sensitivity, we analyzed the phos-
phorylation status of specific regulatory sites of cTnI (Ser-23/24, Ser-43
and Thr-144) and cMyBP-C (Ser-282). These measurements revealed a
robust increment in the phosphorylation of the PKC-dependent Thr-144
site of cTnI in the AB-wk6 group (Fig. 4C). In line with our results, it has
been previously reported that pseudo-phosphorylation of cTnI at Thr-
143/144 (Thr-143 in human and Thr-144 in mouse/rat) potentially
enhances myofilament Ca2+-sensitivity [24,25]. Interestingly, the hy-
perphosphorylation of Thr-143 site did not affect the maximal force
development in human permeabilized cardiomyocytes [24], which
finding is also in good agreement with our results demonstrating un-
altered Fmax in the AB-wk6 group (Table 1). Considering the fact that no
alterations occurred at other sites of cTnI (Ser-22/23 and Ser-43) and
cMyBP-C (Ser-282), it could be hypothesized that hyperpho-
sphorylation of PKC-specific Thr-144 site of cTnI might have pre-
dominantly contributed to the increased myofilament Ca2+ sensitivity
in the AB group at week 6.
Fig. 6. Alterations in preload recruitable stroke work showed strong correlation with changes in myofilament Ca2+ sensitivity during the progression of PO-induced
LVH.
Preload recruitable stroke work (PRSW) indicated increased left ventricular (LV) contractility in the aortic-banded (AB) group at week 6 compared to the corre-
sponding sham group and also to the AB groups at week 12 and 18 (A-B). Strong correlation could be observed between PRSW and pCa50 among all the study groups
(C) and also among only the AB groups (D). No correlation could be detected among the Sham groups (E). LVH indicates left ventricular hypertrophy; PO: pressure
overload. *: P < .05. ***: P < .001.
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Advanced stages of PO-induced LVH. At more advanced stages of PO-
induced LVH, the compensatory increment in LV contractility declined,
as indicated by PeV analysis (Figs. 5B, 6B, 7B). In parallel, we found
that the cellular (enhancement of myofilament Ca2+-sensitivity) and
molecular (cTnI hyperphosphorylation at PKC-specific Thr-144 site)
adaptations also diminished in the AB groups at week 12 and 18
(Figs. 3, 4C). Therefore, in our longitudinal study, alterations of sar-
comere Ca2+-sensitivity as well as cTnI phosphorylation at Thr-144
followed very precisely the changes of LV contractility. Previous studies
conducted on advanced stages of PO-induced LVH found normal or
decreased Ca2+-sensitivity in isolated and skinned single cardiomyo-
cyte preparations. For instance, in a spontaneously hypertensive rat
strain with evident signs of HF, neither pCa50 nor Fmax differed from the
control's level [22]. These results are in good agreement with the pre-
sent findings, demonstrating the lack of cellular compensation to the
increased PO in advanced stages of LVH. Furthermore, in a TAC-in-
duced end-stage HF rat model, both components of myofilament func-
tion (pCa50, Fmax) were substantially decreased [9,10]. It is important to
note that the aortic arch was constricted to a very severe level for a
relatively long experimental period (36 weeks) in the latter studies.
Therefore, it could be hypothesized that in this particular TAC model,
the status of LVH and HF reached a more advanced level compared
either to our abdominal AB or the spontaneously hypertensive rat
models.
Based on our findings and the previous literature data, we hy-
pothesize that increment in myofilament Ca2+-sensitivity (due to hy-
perphosphorylation of the PKC-specific Thr-144 site of cTnI) represents
an early but only temporary adaptation to increased PO. Accordingly,
the initially increased sarcomere Ca2+-sensitivity regresses during the
transition from compensated LVH to early-stage HF and it substantially
reduces at HF.
5. Conclusion
The present paper found that the early-stage of PO-induced LVH is
associated with increased LV contractility on the intact organ level, and
enhanced myofilament Ca2+ sensitivity (due to hyperphosphorylation
of the PKC-specific Thr-144 site of cTnI) on the sarcomere level. This
early functional adaption compensates for the increased afterload re-
sulting in maintained ventriculo-arterial coupling and preserved sys-
tolic function. However, at more advanced stages of PO-induced LVH,
the initial augmentation of LV contractility as well as the increased
myofilament Ca2+ sensitivity decline, leading to impaired ventriculo-
arterial coupling and reduced systolic performance. These data in-
dicate, that changes in sarcomere Ca2+ sensitivity might underlie the
alterations in LV contractility during the development and progression
of PO-induced LVH.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.yjmcc.2019.02.017.
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